Riverview Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.64K	Hold	6	–	–	0.01%	185
2025 Q4	$4.63K	Hold	6	–	–	0.01%	200
2025 Q3	$3.37K	Hold	6	–	–	﹤0.01%	193
2025 Q2	$3.15K	Sell	6 -80	-93%	-$44.7K	﹤0.01%	212
2025 Q1	$54.5K	Hold	86	–	–	0.05%	212
2024 Q4	$61.3K	Sell	86 -24	-22%	-$20.1K	0.06%	203
2024 Q3	$116K	Buy	110 +2	+2%	+$2.23K	0.1%	152
2024 Q2	$114K	Buy	108 +34	+46%	+$33K	0.11%	145
2024 Q1	$71.2K	Buy	+74	New	+$70.4K	0.05%	200
2023 Q4	–	Sell	-74	Closed	-$60.9K	–	515
2023 Q3	$60.9K	Hold	74	–	–	0.05%	211
2023 Q2	$53.2K	Hold	74	–	–	0.05%	200
2023 Q1	$60.8K	Hold	74	–	–	0.06%	185
2022 Q4	$53K	Hold	74	–	–	0.05%	209
2022 Q3	$51K	Hold	74	–	–	0.05%	203
2022 Q2	$44K	Hold	74	–	–	0.04%	231
2022 Q1	$52K	Buy	+74	New	+$46.8K	0.04%	217